| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
Income Statement  | ||||||
| Total Revenue | 83.04M | 83.07M | 106.04M | 104.51M | 60.40M | 45.16M | 
| Gross Profit | 13.87M | 14.40M | 18.73M | 21.09M | 12.24M | 7.33M | 
| EBITDA | 923.42K | -323.37K | 6.58M | 8.27M | 3.93M | -1.89M | 
| Net Income | -2.11M | -3.85M | 909.41K | 8.64M | 1.32M | -5.15M | 
Balance Sheet  | ||||||
| Total Assets | 53.40M | 58.17M | 68.37M | 78.50M | 43.80M | 26.29M | 
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 0.00 | -1.94M | -7.48M | -1.78M | 
| Total Debt | 19.46M | 17.70M | 31.00M | 39.59M | 23.89M | 12.63M | 
| Total Liabilities | 34.00M | 38.56M | 45.83M | 56.09M | 32.08M | 15.73M | 
| Stockholders Equity | 19.41M | 19.61M | 22.54M | 22.41M | 11.72M | 10.56M | 
Cash Flow  | ||||||
| Free Cash Flow | 6.68M | 9.97M | 12.00M | -10.67M | -9.26M | 10.22M | 
| Operating Cash Flow | 6.96M | 10.39M | 12.69M | -8.57M | -9.22M | 10.22M | 
| Investing Cash Flow | -277.82K | -414.09K | -676.64K | -2.10M | 40.11K | 1.43K | 
| Financing Cash Flow | -6.68M | -9.97M | -12.01M | 10.67M | 9.18M | -10.22M | 
Name  | Overall Rating  | Market Cap  | P/E Ratio  | ROE  | Dividend Yield  | Revenue Growth  | EPS Growth  | 
|---|---|---|---|---|---|---|---|
| ― | C$521.72M | 8.11 | 11.66% | 2.77% | 14.74% | 62.76% | |
| ― | C$151.52M | 3.85 | 20.27% | ― | 18.15% | -75.41% | |
| ― | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
| ― | C$398.62M | -19.56 | -5.02% | ― | -6.25% | -129.86% | |
| ― | C$273.99M | 27.79 | 1.53% | ― | -4.63% | -92.13% | |
| ― | $10.41M | 0.39 | -2.30% | ― | -82.87% | ― | |
| ― | C$6.48M | ― | -10.30% | ― | -11.74% | -10.97% | 
Bri-Chem Corp. reported a significant decline in its financial performance for the fourth quarter of 2024, with consolidated sales dropping by 23% to $20.6 million due to decreased U.S. drilling activity. The company’s adjusted EBITDA and operating earnings also saw substantial decreases, alongside a notable reduction in working capital, which was impacted by a loan classification change. Despite these challenges, Bri-Chem received a waiver for a covenant breach from its lender, indicating ongoing financial adjustments and potential future stability.